Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Health services entities : Biodesix, inc. save search
Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024
Published: 2024-04-24 (Crawled : 11:00) - biospace.com/
BDSX | $1.28 1K
|
Health Services
| Email alert
Add to watchlist
first report financial results
Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
Published: 2024-04-05 (Crawled : 13:30) - biospace.com/
BDSX | $1.28 1K
|
Health Services
|
| O: -13.25%
H: 14.5%
C: 6.87%
offering
Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center
Published: 2024-03-25 (Crawled : 12:00) - biospace.com/
BDSX | $1.28 1K
|
Health Services
|
| O: 4.35%
H: 5.56%
C: 0.0%
cancer research agreement
Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights
Published: 2024-03-01 (Crawled : 12:00) - biospace.com/
BDSX | $1.28 1K
|
Health Services
|
| O: 23.38%
H: 1.58%
C: -16.84%
business year results
Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference
Published: 2024-02-26 (Crawled : 12:00) - biospace.com/
BDSX | $1.28 1K
|
Health Services
|
| O: 1.27%
H: 1.87%
C: -4.38%
conference health care
Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024
Published: 2024-02-16 (Crawled : 12:00) - biospace.com/
BDSX | $1.28 1K
|
Health Services
|
| O: -1.27%
H: 6.06%
C: -4.52%
report year financial results
Global Proteomics Strategic Research Report 2023-2030 - U.S. Market is Estimated at $11.5 Billion, While China is Forecast to Grow at 12.8% CAGR
Published: 2023-12-07 (Crawled : 00:00) - prnewswire.com
BDSX | $1.28 1K
|
Health Services
|
| O: 2.67%
H: 7.14%
C: 3.25%
report research global china market
Biodesix Announces Third Quarter 2023 Results and Highlights
Published: 2023-11-07 (Crawled : 00:00) - biospace.com/
BDSX | $1.28 1K
|
Health Services
|
| O: 6.55%
H: 6.15%
C: -4.21%
results
Biodesix to Report Third Quarter 2023 Financial Results on November 7, 2023
Published: 2023-10-24 (Crawled : 11:00) - biospace.com/
BDSX | $1.28 1K
|
Health Services
|
| O: -3.13%
H: 6.01%
C: -1.94%
report financial results
Biodesix to Present New Data on Nodify Lung® Testing at CHEST 2023 Annual Meeting
Published: 2023-10-03 (Crawled : 12:00) - biospace.com/
BDSX | $1.28 1K
|
Health Services
|
| O: 0.0%
H: 2.46%
C: -1.17%
lung meeting
Biodesix Announces Two Presentations on Lung Cancer Treatment Guidance Tests at the IASLC 2023 World Lung Conference on Lung Cancer
Published: 2023-09-07 (Crawled : 13:00) - biospace.com/
BDSX | $1.28 1K
|
Health Services
|
| O: 1.06%
H: 4.2%
C: -2.8%
lung conference world cancer treatment
Biodesix to Participate in Two Upcoming Investor Conferences in September 2023
Published: 2023-09-05 (Crawled : 11:00) - biospace.com/
MS | News 0 d | $93.46 -0.32% 1.2M
|
Finance
|
| O: 0.01%
H: 0.0%
C: 0.0%
BDSX | $1.28 1K
|
Health Services
|
| O: -1.96%
H: 7.33%
C: -10.0%
Biodesix Announces Presentation of New Nodify XL2® Data at AABIP Conference Highlighting Increased Proportion of Biopsies Diagnosing Cancer
Published: 2023-08-22 (Crawled : 12:00) - biospace.com/
BDSX | $1.28 1K
|
Health Services
|
| O: -1.2%
H: 3.05%
C: 3.05%
xl2 conference presentation cancer
Biodesix Announces Second Quarter 2023 Results and Highlights
Published: 2023-08-07 (Crawled : 22:00) - biospace.com/
BDSX | $1.28 1K
|
Health Services
|
| O: 1.9%
H: 1.86%
C: -4.35%
results
Biodesix to Participate in the Canaccord Genuity 43rd Annual Growth Conference
Published: 2023-08-01 (Crawled : 12:00) - biospace.com/
BDSX | $1.28 1K
|
Health Services
|
| O: 5.17%
H: 22.95%
C: 17.21%
conference growth
Biodesix to Report Second Quarter 2023 Financial Results on August 7, 2023
Published: 2023-07-24 (Crawled : 12:00) - biospace.com/
BDSX | $1.28 1K
|
Health Services
|
| O: -3.42%
H: 7.08%
C: 6.19%
report financial results
Biodesix Announces Publication of the ORACLE Clinical Utility Study with the Primary Endpoint Demonstrating that the Nodify XL2® Test Reduced Unnecessary Invasive Procedures on Benign Lung Nodules
Published: 2023-07-12 (Crawled : 12:00) - biospace.com/
BDSX | $1.28 1K
|
Health Services
|
| O: 4.27%
H: 4.92%
C: -3.69%
xl2 lung test publication study
Biodesix Completes Enrollment of INSIGHT Study Assessing Clinical Utility of the VeriStrat® Blood-Based Host Immune Classifier
Published: 2023-06-27 (Crawled : 11:00) - biospace.com/
BDSX | $1.28 1K
|
Health Services
|
| O: -3.33%
H: 6.03%
C: -2.59%
veristrat study
Biodesix Announces Three Abstracts to Be Presented at ASCO 2023 Annual Meeting
Published: 2023-06-01 (Crawled : 11:00) - biospace.com/
BDSX | $1.28 1K
|
Health Services
|
| O: 0.0%
H: 0.71%
C: -0.71%
asco meeting
Biodesix Announces Four Presentations of Health Economic Data Highlighting Cost Saving Potential of Nodify Lung® Testing
Published: 2023-05-25 (Crawled : 12:00) - biospace.com/
BDSX | $1.28 1K
|
Health Services
|
| O: 4.55%
H: 4.35%
C: 0.72%
lung health potential
Gainers vs Losers
| 57% | 43% |
Top 10 Gainers
CSSE 4 | $0.3686 142.02% 76M
|
Consumer Services
CZOO | $11.685 134.17% 7.6M
|
BOF | $2.05 75.21% 78M
|
AMST | $3.14 57.0% 59M
|
Technology Services
LICN | $0.7885 40.8% 11M
|
TROO | $1.51 38.53% 5.6M
|
Manufacturing
MULN | News | $3.7 35.53% 6.4M
|
Information
WHLM | $6.61 30.12% 400K
|
Commercial Services
RILY | $27.91 28.5% 8.9M
|
Finance
RBBN 4 | $3.25 26.46% 1.5M
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.